BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24657661)

  • 1. Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an interleukin 8-dependent survival of leukemia cells.
    Corrado C; Raimondo S; Saieva L; Flugy AM; De Leo G; Alessandro R
    Cancer Lett; 2014 Jun; 348(1-2):71-6. PubMed ID: 24657661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic myelogenous leukaemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor.
    Corrado C; Saieva L; Raimondo S; Santoro A; De Leo G; Alessandro R
    J Cell Mol Med; 2016 Oct; 20(10):1829-39. PubMed ID: 27196940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes.
    Jafarzadeh N; Safari Z; Pornour M; Amirizadeh N; Forouzandeh Moghadam M; Sadeghizadeh M
    J Cell Physiol; 2019 Apr; 234(4):3697-3710. PubMed ID: 30317554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism.
    Raimondo S; Saieva L; Corrado C; Fontana S; Flugy A; Rizzo A; De Leo G; Alessandro R
    Cell Commun Signal; 2015 Feb; 13():8. PubMed ID: 25644060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic myelogenous leukemia cells remodel the bone marrow niche via exosome-mediated transfer of miR-320.
    Gao X; Wan Z; Wei M; Dong Y; Zhao Y; Chen X; Li Z; Qin W; Yang G; Liu L
    Theranostics; 2019; 9(19):5642-5656. PubMed ID: 31534508
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis.
    Taverna S; Flugy A; Saieva L; Kohn EC; Santoro A; Meraviglia S; De Leo G; Alessandro R
    Int J Cancer; 2012 May; 130(9):2033-43. PubMed ID: 21630268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between CML cells with HUVECS and BMSCs through CML derived exosomes.
    Cetin Z; Ilker Saygili E; Yilmaz M
    Front Biosci (Landmark Ed); 2021 Jan; 26(3):444-467. PubMed ID: 33049677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokines as a Conductor of Bone Marrow Microenvironment in Chronic Myeloid Leukemia.
    Mukaida N; Tanabe Y; Baba T
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28829353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal shuttling of miR-126 in endothelial cells modulates adhesive and migratory abilities of chronic myelogenous leukemia cells.
    Taverna S; Amodeo V; Saieva L; Russo A; Giallombardo M; De Leo G; Alessandro R
    Mol Cancer; 2014 Jul; 13():169. PubMed ID: 25015105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes from mesenchymal stromal cells enhance imatinib-induced apoptosis in human leukemia cells via activation of caspase signaling pathway.
    Liu Y; Song B; Wei Y; Chen F; Chi Y; Fan H; Liu N; Li Z; Han Z; Ma F
    Cytotherapy; 2018 Feb; 20(2):181-188. PubMed ID: 29269240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K562 cell-derived exosomes suppress the adhesive function of bone marrow mesenchymal stem cells via delivery of miR-711.
    Jiang YH; Liu J; Lin J; Li SQ; Xu YM; Min QH; Zhong QH; Sun F; Li J; You XH; Liao KL; Qin TY; Zhao C; Huang B; Wang XZ
    Biochem Biophys Res Commun; 2020 Jan; 521(3):584-589. PubMed ID: 31677790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citrus limon-derived nanovesicles inhibit cancer cell proliferation and suppress CML xenograft growth by inducing TRAIL-mediated cell death.
    Raimondo S; Naselli F; Fontana S; Monteleone F; Lo Dico A; Saieva L; Zito G; Flugy A; Manno M; Di Bella MA; De Leo G; Alessandro R
    Oncotarget; 2015 Aug; 6(23):19514-27. PubMed ID: 26098775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological and In Vivo Microscopic Analysis of the Bone Marrow Microenvironment in a Murine Model of Chronic Myelogenous Leukemia.
    Weissenberger ES; Krause DS
    Methods Mol Biol; 2016; 1465():59-72. PubMed ID: 27581139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling chronic myeloid leukemia in immunodeficient mice reveals expansion of aberrant mast cells and accumulation of pre-B cells.
    Askmyr M; Ågerstam H; Lilljebjörn H; Hansen N; Karlsson C; von Palffy S; Landberg N; Högberg C; Lassen C; Rissler M; Richter J; Ehinger M; Järås M; Fioretos T
    Blood Cancer J; 2014 Dec; 4(12):e269. PubMed ID: 25501026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcr-Abl-mediated suppression of normal hematopoiesis in leukemia.
    Lin H; Monaco G; Sun T; Ling X; Stephens C; Xie S; Belmont J; Arlinghaus R
    Oncogene; 2005 May; 24(20):3246-56. PubMed ID: 15735695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthelmintic Niclosamide Disrupts the Interplay of p65 and FOXM1/β-catenin and Eradicates Leukemia Stem Cells in Chronic Myelogenous Leukemia.
    Jin B; Wang C; Li J; Du X; Ding K; Pan J
    Clin Cancer Res; 2017 Feb; 23(3):789-803. PubMed ID: 27492973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CML derived exosomes promote tumor favorable functional performance in T cells.
    Jafarzadeh N; Gholampour MA; Alivand MR; Kavousi S; Arzi L; Rad F; Sadeghizadeh M; Pornour M
    BMC Cancer; 2021 Sep; 21(1):1002. PubMed ID: 34493241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Potential of Exosomes Derived from Chronic Myelogenous Leukaemia Cells as a Biomarker.
    Kang KW; Jung JH; Hur W; Park J; Shin H; Choi B; Jeong H; Kim DS; Yu ES; Lee SR; Sung HJ; Kim SJ; Choi CW; Kim HK; Hong S; Park JH; Choi Y; Park Y; Kim BS
    Anticancer Res; 2018 Jul; 38(7):3935-3942. PubMed ID: 29970515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 3- receptor targeted exosomes inhibit
    Bellavia D; Raimondo S; Calabrese G; Forte S; Cristaldi M; Patinella A; Memeo L; Manno M; Raccosta S; Diana P; Cirrincione G; Giavaresi G; Monteleone F; Fontana S; De Leo G; Alessandro R
    Theranostics; 2017; 7(5):1333-1345. PubMed ID: 28435469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF2-FGFR1 signaling regulates release of Leukemia-Protective exosomes from bone marrow stromal cells.
    Javidi-Sharifi N; Martinez J; English I; Joshi SK; Scopim-Ribeiro R; Viola SK; Edwards DK; Agarwal A; Lopez C; Jorgens D; Tyner JW; Druker BJ; Traer E
    Elife; 2019 Feb; 8():. PubMed ID: 30720426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.